Literature DB >> 14638697

Sarco(endo)plasmic reticulum Ca2+ ATPases (SERCA1 and -2) in human extraocular muscles.

Daniel Kjellgren1, Michelle Ryan, Kay Ohlendieck, Lars-Eric Thornell, Fatima Pedrosa-Domellöf.   

Abstract

PURPOSE: To investigate the composition of the fibers in human extraocular muscles (EOMs) with respect to the sarco(endo)plasmic reticulum Ca(2+)ATPases (SERCA)-1 and -2 and to investigate possible correlations between SERCA and myosin heavy chain (MyHC) composition.
METHODS: EOM samples were processed for immunocytochemistry with monoclonal antibodies specific against SERCA1 (fast isoform), SERCA2 (slow isoform), or different MyHCs. A total of 1571 fibers were analyzed. Microsomal EOM fractions were analyzed with SDS-PAGE and immunoblots.
RESULTS: The fast fibers, containing MyHCIIa, accounted for 79% of the fibers in the orbital layer (OL) and 74% in the global layer (GL). More than 99% of these fibers contained SERCA1, and 86% of them coexpressed SERCA1 and -2. Almost all slow fibers stained with SERCA2; 54% of those in the GL and all in the OL coexpressed SERCA1 and -2. Fifteen percent of the fibers in the GL and less than 1% in the OL were MyHCeom(pos)/MyHCIIa(neg) fibers. All these contained SERCA1 and in the OL also stained strongly with anti-SERCA2. Biochemically SERCA2 was more abundant than SERCA1.
CONCLUSIONS: The human EOMs had a very complex pattern of expression of the major protein regulating fiber relaxation rate. The coexistence of SERCA1 and -2, together with complex mixtures of MyHCs in most of the fibers provide the human EOMs with a unique molecular portfolio that allows a highly specific fine-tuning regimen of contraction and relaxation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14638697     DOI: 10.1167/iovs.03-0218

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  9 in total

1.  Genomic profiling reveals Pitx2 controls expression of mature extraocular muscle contraction-related genes.

Authors:  Yuefang Zhou; Bendi Gong; Henry J Kaminski
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-18       Impact factor: 4.799

2.  Distinctive patterns of microRNA expression in extraocular muscles.

Authors:  Ulrike Zeiger; Tejvir S Khurana
Journal:  Physiol Genomics       Date:  2010-02-09       Impact factor: 3.107

3.  Wnt and extraocular muscle sparing in amyotrophic lateral sclerosis.

Authors:  Linda K McLoon; Vahid M Harandi; Thomas Brännström; Peter M Andersen; Jing-Xia Liu
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-14       Impact factor: 4.799

4.  A continuum of myofibers in adult rabbit extraocular muscle: force, shortening velocity, and patterns of myosin heavy chain colocalization.

Authors:  Linda K McLoon; Han Na Park; Jong-Hee Kim; Fatima Pedrosa-Domellöf; Ladora V Thompson
Journal:  J Appl Physiol (1985)       Date:  2011-07-21

5.  Superior calcium homeostasis of extraocular muscles.

Authors:  Ulrike Zeiger; Claire H Mitchell; Tejvir S Khurana
Journal:  Exp Eye Res       Date:  2010-08-07       Impact factor: 3.467

6.  Distribution of SERCA isoforms in human intrafusal fibers.

Authors:  Jing-Xia Liu; Lars-Eric Thornell; Fatima Pedrosa-Domellöf
Journal:  Histochem Cell Biol       Date:  2003-09-12       Impact factor: 4.304

7.  A musculoskeletal model of low grade connective tissue inflammation in patients with thyroid associated ophthalmopathy (TAO): the WOMED concept of lateral tension and its general implications in disease.

Authors:  Roy Moncayo; Helga Moncayo
Journal:  BMC Musculoskelet Disord       Date:  2007-02-23       Impact factor: 2.362

8.  Prolongation of Relaxation Time in Extraocular Muscles With Brain Derived Neurotrophic Factor in Adult Rabbit.

Authors:  Krysta R Nelson; Shanlee M Stevens; Linda K McLoon
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-10-01       Impact factor: 4.799

9.  Transcriptome-scale similarities between mouse and human skeletal muscles with normal and myopathic phenotypes.

Authors:  Alvin T Kho; Peter B Kang; Isaac S Kohane; Louis M Kunkel
Journal:  BMC Musculoskelet Disord       Date:  2006-03-07       Impact factor: 2.362

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.